Request Demo
Last update 18 Oct 2025
BrAD-R13
Last update 18 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 7,8-dihydroxyflayone derivative (Shanghai Braegen Pharmaceutical), BRAD R13, BRAD-R13 + [2] |
Target |
Action stimulants |
Mechanism TrkB stimulants(Neurotrophic tyrosine kinase receptor type 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with BrAD-R13ChiCTR2300078487
Evaluation of the safety, tolerability, and pharmacokinetics of BrAD-R13 in healthy Chinese subjects: a single center, randomized, double-blind, single dose, and multiple dose study
CTR20233658
评估在中国健康受试者进行的单中心、随机、双盲、单次、多次给药BrAD-R13的安全性、耐受性和药代动力学特征、食物影响和物质平衡研究。
[Translation] A single-center, randomized, double-blind, single- and multiple-dose study of BrAD-R13 was conducted in healthy Chinese subjects to evaluate its safety, tolerability, pharmacokinetic characteristics, food effects, and material balance.
100 Clinical Results associated with BrAD-R13
Login to view more data
100 Translational Medicine associated with BrAD-R13
Login to view more data
100 Patents (Medical) associated with BrAD-R13
Login to view more data
100 Deals associated with BrAD-R13
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 1 | United States | 01 May 2019 | |
| Schizophrenia | Preclinical | China | 29 Aug 2024 | |
| Amyotrophic Lateral Sclerosis | Preclinical | China | 11 May 2024 | |
| ischemic brain injury | Preclinical | China | 11 May 2024 | |
| Acute Ischemic Stroke | Preclinical | - | - | |
| Depressive Disorder | Preclinical | China | - | |
| Parkinson Disease | Preclinical | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free